David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.36% |
| 2 | Consumer Discretionary | 9.47% |
| 3 | Financials | 6.95% |
| 4 | Healthcare | 6.38% |
| 5 | Communication Services | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Pacira BioSciences
PCRX
$1.03B
| $7.03M | 0.01% |
240,439
+34,423
| +17% | +$1.06M |
|
1527
CALL
NRG Energy
NRG
$24.4B
| $7.01M | 0.01% |
103,600
+43,600
| +73% | +$2.45M |
|
1528
Theravance Biopharma
TBPH
$884M
| $7.01M | 0.01% |
781,585
-69,623
| -8% | -$645K |
|
1529
Ionis Pharmaceuticals
IONS
$10.5B
| $6.96M | 0.01% |
160,482
+41,324
| +35% | +$1.97M |
|
1530
CALL
Cloudflare
NET
$101B
| $6.95M | 0.01% |
71,800
-249,100
| -78% | -$22.6M |
|
1531
CALL
Newmont
NEM
$139B
| $6.93M | 0.01% |
193,400
+126,800
| +190% | +$4.37M |
|
1532
PUT
Tapestry
TPR
$26B
| $6.92M | 0.01% |
145,800
-69,300
| -32% | -$2.97M |
|
1533
Hancock Whitney
HWC
$6.04B
| $6.92M | 0.01% |
150,212
+90,877
| +153% | +$4.04M |
|
1534
XPO
XPO
$22.5B
| $6.92M | 0.01% |
56,670
-78,353
| -58% | -$8.39M |
|
|
NML
1535
Neuberger Energy Infrastructure and Income Fund Inc
NML
$600M
| $6.91M | 0.01% |
937,076
-201,075
| -18% | -$1.38M |
|
1536
CALL
Credit Acceptance
CACC
$6.16B
| $6.89M | 0.01% |
12,500
-10,300
| -45% | -$5.65M |
|
1537
PUT
Enbridge
ENB
$110B
| $6.87M | 0.01% |
190,000
-20,000
| -10% | -$710K |
|
1538
Mercury Systems
MRCY
$5.4B
| $6.86M | 0.01% |
232,640
+158,917
| +216% | +$4.79M |
|
1539
PUT
Penumbra
PEN
$12.7B
| $6.85M | 0.01% |
30,700
| – | – |
|
|
EB
1540
DELISTED
Eventbrite
EB
| $6.82M | 0.01% |
1,244,844
-535,899
| -30% | -$3.89M |
|
1541
Cannae Holdings
CNNE
$671M
| $6.82M | 0.01% |
306,468
+123,171
| +67% | +$2.6M |
|
1542
Tidewater
TDW
$4.42B
| $6.77M | 0.01% |
73,536
+34,496
| +88% | +$2.57M |
|
1543
Alpha Metallurgical Resources
AMR
$2.76B
| $6.76M | 0.01% |
20,423
+8,084
| +66% | +$2.96M |
|
1544
Inspire Medical Systems
INSP
$1.79B
| $6.76M | 0.01% |
31,488
-153,460
| -83% | -$30.1M |
|
1545
Pitney Bowes
PBI
$2.33B
| $6.75M | 0.01% |
1,558,754
-569,677
| -27% | -$2.35M |
|
1546
American States Water
AWR
$3.56B
| $6.75M | 0.01% |
93,400
+13,303
| +17% | +$992K |
|
1547
CALL
MetLife
MET
$61.3B
| $6.74M | 0.01% |
90,900
-290,000
| -76% | -$20.2M |
|
1548
LiveRamp
RAMP
$2.29B
| $6.73M | 0.01% |
195,204
-375,095
| -66% | -$13.8M |
|
|
P
1549
Everpure Inc
P
$36.2B
| $6.7M | 0.01% |
128,877
-91,592
| -42% | -$4.09M |
|
1550
Jones Lang LaSalle
JLL
$17.8B
| $6.69M | 0.01% |
34,307
+20,223
| +144% | +$3.68M |
|
Similar funds
David Shaw's Q1 2024 Portfolio in Review
As of Q1 2024, David Shaw held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
David Shaw withdrew a net $8.58B in Q1 2024, closing 634 positions and reducing 1,722 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $307M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, David Shaw opened a new position in Arm worth $297M.
- David Shaw's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- David Shaw added most to Apple in Q1 2024, an estimated $820M increase.
- David Shaw's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- David Shaw fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- David Shaw's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- David Shaw opened 655 new positions and closed 634 in Q1 2024.
- David Shaw's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.